Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.1 USD | -0.51% | +0.66% | +20.24% |
05-15 | Merck to present new oncology data | CF |
05-14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.24% | 334B | |
+33.02% | 709B | |
+30.77% | 595B | |
-1.82% | 367B | |
+5.93% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+8.89% | 171B | |
+0.36% | 163B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- UBS Adjusts Merck & Company Price Target to $135 From $122, Maintains Buy Rating